Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Correction of cognitive deficits in mouse models of Down syndrome by a pharmacological inhibitor of DYRK1A.

Nguyen TL, Duchon A, Manousopoulou A, Loaëc N, Villiers B, Pani G, Karatas M, Mechling AE, Harsan LA, Limanton E, Bazureau JP, Carreaux F, Garbis SD, Meijer L, Herault Y.

Dis Model Mech. 2018 Sep 27;11(9). pii: dmm035634. doi: 10.1242/dmm.035634.

2.

Casein kinase 1ε and 1α as novel players in polycystic kidney disease and mechanistic targets for (R)-roscovitine and (S)-CR8.

Billot K, Coquil C, Villiers B, Josselin-Foll B, Desban N, Delehouzé C, Oumata N, Le Meur Y, Boletta A, Weimbs T, Grosch M, Witzgall R, Saunier S, Fischer E, Pontoglio M, Fautrel A, Mrug M, Wallace D, Tran PV, Trudel M, Bukanov N, Ibraghimov-Beskrovnaya O, Meijer L.

Am J Physiol Renal Physiol. 2018 Jul 1;315(1):F57-F73. doi: 10.1152/ajprenal.00489.2017. Epub 2018 Mar 14.

3.

Vantage sensitivity: a framework for individual differences in response to psychological intervention.

de Villiers B, Lionetti F, Pluess M.

Soc Psychiatry Psychiatr Epidemiol. 2018 Jun;53(6):545-554. doi: 10.1007/s00127-017-1471-0. Epub 2018 Jan 4. Review.

4.

Marine-Derived 2-Aminoimidazolone Alkaloids. Leucettamine B-Related Polyandrocarpamines Inhibit Mammalian and Protozoan DYRK & CLK Kinases.

Loaëc N, Attanasio E, Villiers B, Durieu E, Tahtouh T, Cam M, Davis RA, Alencar A, Roué M, Bourguet-Kondracki ML, Proksch P, Limanton E, Guiheneuf S, Carreaux F, Bazureau JP, Klautau M, Meijer L.

Mar Drugs. 2017 Oct 17;15(10). pii: E316. doi: 10.3390/md15100316. Review.

5.

Comparison of titrable thermoplastic versus custom-made mandibular advancement device for the treatment of obstructive sleep apnoea.

Gagnadoux F, Nguyen XL, Le Vaillant M, Priou P, Meslier N, Eberlein A, Kun-Darbois JD, Chaufton C, Villiers B, Levy M, Trzépizur W, Launois S.

Respir Med. 2017 Oct;131:35-42. doi: 10.1016/j.rmed.2017.08.004. Epub 2017 Aug 4.

PMID:
28947040
6.

Exploration of the imidazo[1,2-b]pyridazine scaffold as a protein kinase inhibitor.

Bendjeddou LZ, Loaëc N, Villiers B, Prina E, Späth GF, Galons H, Meijer L, Oumata N.

Eur J Med Chem. 2017 Jan 5;125:696-709. doi: 10.1016/j.ejmech.2016.09.064. Epub 2016 Sep 22.

PMID:
27721154
7.

USER friendly DNA recombination (USERec): gene library construction requiring minimal sequence homology.

Villiers B, Hollfelder F.

Methods Mol Biol. 2014;1179:213-24. doi: 10.1007/978-1-4939-1053-3_15.

PMID:
25055781
8.

IS6110 restriction fragment length polymorphism typing of drug-resistant Mycobacterium tuberculosis strains from northeast South Africa.

Green E, Obi LC, Okoh AI, Nchabeleng M, de Villiers BE, Letsoalo T, Hoosen AA, Bessong PO, Ndip RN.

J Health Popul Nutr. 2013 Mar;31(1):1-10.

9.

When precaution creates misunderstandings: the unintended effects of precautionary information on perceived risks, the EMF case.

Wiedemann PM, Schuetz H, Boerner F, Clauberg M, Croft R, Shukla R, Kikkawa T, Kemp R, Gutteling JM, de Villiers B, da Silva Medeiros FN, Barnett J.

Risk Anal. 2013 Oct;33(10):1788-801. doi: 10.1111/risa.12034. Epub 2013 Mar 28.

PMID:
23551041
10.

Antibiotic susceptibilities and resistance genes of Ureaplasma parvum isolated in South Africa.

Govender S, Gqunta K, le Roux M, de Villiers B, Chalkley LJ.

J Antimicrob Chemother. 2012 Dec;67(12):2821-4. doi: 10.1093/jac/dks314. Epub 2012 Aug 9.

PMID:
22879459
11.

Directed evolution of a gatekeeper domain in nonribosomal peptide synthesis.

Villiers B, Hollfelder F.

Chem Biol. 2011 Oct 28;18(10):1290-9. doi: 10.1016/j.chembiol.2011.06.014.

12.

Antimicrobial and antimalarial activity of Cussonia species (Araliaceae).

De Villiers BJ, Van Vuuren SF, Van Zyl RL, Van Wyk BE.

J Ethnopharmacol. 2010 May 27;129(2):189-96. doi: 10.1016/j.jep.2010.02.014. Epub 2010 Mar 16.

PMID:
20298772
13.

Drug-susceptibility patterns of Mycobacterium tuberculosis in Mpumalanga province, South Africa: possible guiding design of retreatment regimen.

Green E, Obi CL, Nchabeleng M, de Villiers BE, Sein PP, Letsoalo T, Hoosen AA, Bessong PO, Ndip RN.

J Health Popul Nutr. 2010 Feb;28(1):7-13.

14.

USER friendly DNA recombination (USERec): a simple and flexible near homology-independent method for gene library construction.

Villiers BR, Stein V, Hollfelder F.

Protein Eng Des Sel. 2010 Jan;23(1):1-8. doi: 10.1093/protein/gzp063.

PMID:
19897542
15.

Mapping the limits of substrate specificity of the adenylation domain of TycA.

Villiers BR, Hollfelder F.

Chembiochem. 2009 Mar 2;10(4):671-82. doi: 10.1002/cbic.200800553.

PMID:
19189362
16.

An optimized ATP/PP(i)-exchange assay in 96-well format for screening of adenylation domains for applications in combinatorial biosynthesis.

Otten LG, Schaffer ML, Villiers BR, Stachelhaus T, Hollfelder F.

Biotechnol J. 2007 Feb;2(2):232-40.

PMID:
17294409
17.

Possible radiation injury at Koeberg Nuclear Power Station. Organization of medical care.

van Rensburg LC, de Villiers B, van Zyl CJ.

S Afr Med J. 1986 Oct 11;70(8):487-9.

PMID:
3775588
18.

[The patient, the family physician and the specialist].

de Villiers B.

S Afr Med J. 1967 Dec 16;41(46):1196-9. Afrikaans. No abstract available.

PMID:
6080168

Supplemental Content

Loading ...
Support Center